Deep dives into the intersection of technology, regulation, and strategic decision-making.
A short, practical way to work out where your AI system sits under the EU AI Act: prohibited, high-risk, transparency tier or minimal, with the deadline that applies to each.
The Digital Omnibus delayed the EU AI Act's high-risk deadlines to 2027 and 2028, but key obligations already apply and one lands this December. The new timeline, explained by an IT lawyer.
What the EDPB-EDPS Joint Opinion 3/2026 on the European Biotech Act means for clinical trials, health data and AI - a practical briefing for sponsors, biotech developers and AI providers.